Geri Eaves, BSN, RN, CASC, CNOR CEO/Administrator, Bone and Joint Institute of Tennessee Surgery Center

This episode recorded live at Becker’s 31st Annual The Business and Operations of ASCs features Geri Eaves, BSN, RN, CASC, CNOR CEO/Administrator, Bone and Joint Institute of Tennessee Surgery Center. She discusses the market forces accelerating ASC growth, the transformative impact of robotics and technology, and how deeper partnerships and strategic leadership will define success in the years ahead.

In this episode, Frank D. Vrionis, M.D., M.P.H., PhD, Chief of Neurosurgery at the Marcus Neuroscience Institute, discusses the evolving role of AI in research, the growing impact of motion preservation technologies, and the challenges insurance barriers pose to innovation. He shares how his team is planning for growth, advancing spine care, and educating patients on the expanding range of treatment options.

On this episode, James Mooney, Aa complex and minimally invasive spine surgeon with VCU Health, joins the podcast to discuss the rapidly evolving future of spine surgery. He explores how AI is helping standardize clinical decision-making, the continued growth of minimally invasive and patient-specific technologies, and what increasing AI involvement means for the spine field in the years ahead.

On this episode, David L. Skaggs, MD, Co-Director of Cedars-Sinai Spine, Executive Vice Chair of the Department of Orthopaedics at Cedars-Sinai, and Director of Pediatric Orthopaedics at Guerin Children’s, joins the podcast to discuss recent innovations in spine care, including synthetic CT scans generated from MRIs and the advancement of outpatient pediatric spine surgery. He also shares insights on developing surgical tools tailored for physicians with smaller hands, and looks ahead at healthcare trends, particularly how AI-driven solutions can make care more accessible and affordable.

On this episode, Thomas Hutchinson, Administrator of the Surgery Center of Central Florida, joins the podcast to discuss the trends he’s watching—including staffing challenges and impacts of government shutdowns—as well as electrophysiology ablations in the outpatient setting and opportunities for future growth.

This episode recorded live at Becker’s 31st Annual The Business and Operations of ASCs features Jeffrey Singerman, Administrator and COO, Manhattan Endoscopy Center. He discusses key market forces driving ASC growth, the emerging impact of AI on clinical and administrative functions, and how partnerships can strengthen recruitment, staffing, and long term sustainability.

This episode recorded live at Becker’s 31st Annual The Business and Operations of ASCs features Dr. Alaa Abd-Elsayed, Medical Director, UW Health Pain Services. He discusses the rapid growth of ASC models, how AI driven tools are improving efficiency and reducing administrative burden, and why joint ventures and collaboration are key to strengthening patient care and financial sustainability.

This episode recorded live at Becker’s 31st Annual The Business and Operations of ASCs features Dr. Benjamin Levy, Gastroenterologist and Clinical Associate of Medicine, University of Chicago Medicine. He discusses rising demand for colonoscopy driven by updated screening guidelines, the value of ASC partnerships, and how emerging AI tools are transforming documentation, polyp detection, and overall efficiency in GI care.

In this episode, Brett Maxfield, MS, CRNA and President and CEO of Maxfield Healthcare Solutions, shares the top trends shaping ASCs today, including rising costs, anesthesia shortages, and the growing impact of AI. He also discusses technology adoption challenges, evolving specialties, and what he’s watching for ASC growth in the year ahead.

On this episode, Dr. Scott L. Blumenthal, Spine Surgeon at Texas Back Institute, joins the podcast to discuss the latest insights in disc replacements, including new research and the root causes of complications. He also shares his perspective on the role of private insurance in patient access and breaks down the biggest disruptors he expects to shape spine surgery in 2026, particularly growing restrictions around advanced technologies.